Cytyc Corporation's Clinical Technologies Advisory Board (CTAB) provides expert and candid advice on the merits and clinical utility of new diagnostic and therapeutic technologies. The advisors also help evaluate and further develop Cytyc's existing product line and provide guidance on research programs underway with Cytyc's academic partners. CTAB is comprised of distinguished thought leaders in the field of women's health, representing a range of medical specialties including obstetrics and gynecology, gynecologic oncology, pathology, molecular microbiology, immunology, and epidemiology.

The members of the CTAB are as follows:

Jeff Boyd, Ph.D, specializes in cancer research at the molecular level, exploring genetic alterations involved with uterine, ovarian, and breast cancers. He has pioneered the analysis of flaws in the BRCA-1 gene, which is involved in hereditary ovarian cancer, and also spearheads research into estrogen's role in cancer. He has authored more than 150 peer-reviewed journal articles, proceedings, and book chapters on the molecular basis of and the genetic involvement in cancer. Dr. Boyd is Associate Editor of Molecular Carcinogenesis and is on the editorial board of the American Journal of Pathology. He received his undergraduate degree from Duke University in Durham, North Carolina, and his Ph.D from North Carolina State University. Prior to going to Memorial Sloan-Kettering, Dr. Boyd held positions with the National Institute of Health, the University of North Carolina, and the University of Pennsylvania.

Philip D. Darney, MD, MSc

Philip D. Darney, MD, has authored more than 200 scientific papers, scholarly reviews, and book chapters on contraception, and has written three books on family planning. Under his direction, the UCSF Center for Reproductive Health, Research, and Policy has conducted investigations of contraceptives for the National Institutes of Health, the Centers for Disease Control, and private foundations and firms. The UCSF Center trains gynecologists from all over the world in family planning technology. Dr. Darney has been on the medical faculties of UCSF, the Oregon Health Sciences University, and Harvard University. Over the past 25 years he has also served as scientific advisor to the U.S. Agency for International Development, Pathfinder International, and the American Public Health Association, among others. In addition, he has served as visiting professor or consultant in dozens of countries around the world. He received his MD from UCSF and his MSc from the London School of Hygiene and Tropical Medicine.

Thomas F. Purdon, MD, FACOG

Dr. Purdon's research contributions have been made in the areas of hormone therapy, estrogen therapy in surgically induced menopausal women, and dysfunctional uterine bleeding for the Surgical Treatment Outcomes Project. He is a recent Past-President of the American College of Obstetricians and Gynecologists (ACOG), as well as Past-President of the advocacy group, Ob-Gyns for Women's Health. Dr. Purdon is also Secretary for the International Society for Cancer Risk Assessment and Management and was previously on the governing board for the Jacobs Institute of Women's Health. With a life-long commitment to improving the health outcomes for women, Dr. Purdon speaks frequently to the national medical community on the management of abnormal uterine bleeding, risk assessment strategies for breast cancer, and the continuing controversy over hormone therapy. He is also a consultant for United Community Health Centers, a community-based group of clinics in Southern Arizona that cares for patients of all socio-economic levels.

John Thomas Repke, MD

John Thomas Repke, MD, has been the principle investigator or co-investigator for studies designed to provide comprehensive prenatal health care to adolescent patients. Other areas of his research and expertise include HIV and AIDS in pregnancy, and labor and delivery management. For a number of years Dr. Repke has been the Course Director of the Hypertension in Pregnancy Course offered by the American College of Obstetricians and Gynecologists at its annual clinical meeting, and he is the immediate Past-President of the North American Society for the Study of Hypertension in Pregnancy. He has authored 200 journal articles, book chapters, and reviews, and he serves as a reviewer for many peer-reviewed journals, including Obstetrics and Gynecology, American Journal of Perinatology, International Journal of Gynecology and Obstetrics, Journal of the Society of Gynecologic Investigation, and the New England Journal of Medicine. He is also a consultant for the Food and Drug Administration. Having received his BS degree from Georgetown University and his MD degree from the New York Medical College, he completed his post-doctoral training at The Johns Hopkins Hospital in Baltimore.

Lawrence N. Shulman, MD

Dr. Shulman specializes in treating breast cancer and lymphomas, as well as developing new cancer therapies. As a researcher, he is often in a leadership role in numerous clinical trials investigating experimental agents, researching agents such as mutant adenoviruses, or testing new combinations of approved agents. For Dr. Shulman, teaching has always been a priority. He established an oncology fellowship program at Brigham and Women's Hospital, and he has supervised fellows, interns, and residents at Harvard, Beth Israel Hospital, Dana-Farber Cancer Institute and Brigham and Women's Hospital. He is Editor-in-Chief of the American Journal of Oncology Review, and he is a reviewer for the Journal of Clinical Oncology, Cancer, and the New England Journal of Medicine. Dr. Shulman was born in New York City, received his undergraduate degree from Syracuse University, and received his medical degree from Harvard University.

Elizabeth A. Stewart, MD

Elizabeth A. Stewart, MD, specializes in innovative treatments for benign uterine tumors and abnormal uterine bleeding. She is also recognized for her work in infertility, endocrinology, and specifically hormonal effects on reproductive tissues. She has been the principal investigator of a number of clinical trials, several of which examined the association between hormones and benign gynecologic disease. In addition, Dr. Stewart serves as a reviewer of a number of journals, among them the American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology, Journal of the Society for Gynecologic Investigation, and Journal of the National Cancer Institute. She received her BA from Vanderbilt University in molecular biology and her MD from Harvard Medical School. She is Board-Certified in Obstetrics and Gynecology and Reproductive Endocrinology.

Jonathan Zenilman, MD

Dr. Jonathan Zenilman is an international authority on the clinical epidemiology and management of sexually transmitted diseases and HIV prevention, infectious disease surveillance, and has served on U.S. government, international and non-profit advisory committees, including the National Institutes of Health and the Institute of Medicine. Besides clinical care, Dr. Zenilman is the Director of the Johns Hopkins Center for STD Research and Prevention, manages a large extramurally funded research program, teaches at the Johns Hopkins School of Public Health, mentors the research of Ph.D and postdoctoral students, and has authored more than 180 publications. His current research interests include STD epidemiology, HIV/STD prevention behavioral interventions, evaluation of molecular diagnostic tests for infectious disease, and the development of internet-based distance education in infectious diseases and public health. Dr. Zenilman received a BA in Chemistry with honors from Cornell and his MD at SUNY Downstate.

(Participation by individual advisors does not constitute or imply endorsement by the institutions and organizations to which they are affiliated.)